Prodotti
Con più di 60 anni di esperienza nel mondo farmaceutico, la passione e l’impegno nella ricerca, nello sviluppo di farmaci innovativi ed equivalenti, il Laboratorio Farmaceutico CT Srl è diventato un partner affidabile e flessibile nella Supply Chain di prodotti farmaceutici nelle seguenti aree :
- Antibiotici iniettabili Cefalosporanici |
- Prodotti liquidi iniettabili in fiale |
- Prodotti non antibiotici orali solidi e liquidi |
- Prodotti contenenti sostanze stupefacenti e controllate |
Product lists |
|
Active Ingredient |
Pharmaceutical Form |
Atenolol |
100 mg tablets - 50 tablets |
Amikacin |
1g/4ml injectable solution – 1 ampoule 4 ml |
Amikacin |
500mg/2ml injectable solution – 1 ampoule 2 ml |
Ceftriaxone |
1g/3,5ml powder and solvent for injectable solution for IM use – 1 vial powder + 1 ampoule solvent |
Ceftazidime |
1g/3ml powder and solvent for injectable solution for IM use – 1 vial powder + 1 ampoule solvent |
Diosmine |
300 mg tablets – 20 tablets |
Ciprofloxacin |
500 mg film coated tablets - 6 tablets |
Ciprofloxacin |
750 mg film coated tablets - 12 tablets |
Fluconazole |
100 mg hard capsules - 10 capsules |
Fluconazole |
150 mg hard capsules - 2 capsules |
Fluconazole |
200 mg hard capsules - 7 capsules |
Thiocolchicoside |
2 mg/ml injectable solution - 6 ampoules 2 ml |
Piperacillin-Tazobactam |
2g+0.25g/4ml powder and solvent for Injectable solution for IM use– 1 vial powder + 1 ampoule solvent |
Piperacillin-Tazobactam |
4g+0.5g powder for solution for infusion – 1 vial powder |
Glutathione |
600mg/4ml powder and solvent for injectable solution – 10 vials powder + 10 ampoules solvent |
Citicoline |
1g/4ml injectable solution – 3-5 ampoules 4ml |
Citicoline |
500mg/4ml injectable solution – 3-5 ampoules 4ml |
Levofloxacine |
250 mg film coated tablets – 5 tablets |
Levofloxacine |
500 mg film coated tablets – 5 tablets |
Valsartan |
40 mg film coated tablets – 14 tablets |
Valsartan |
80 mg film coated tablets – 28 tablets |
Valsartan |
160 mg film coated tablets – 28 tablets |
“Dossiers and products are available only for countries where they do not infringe patents or intellectual rights”